We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Snibe Co.,Ltd.

Shenzhen New Industries Biomedical Engineering Co., Ltd. (Snibe) is a global leader in the IVD field, with 30 years o... read more Featured Products: More products

Download Mobile App





SNIBE Displays Super High Throughput CLIA Analyzer Powered by X Tech Technology

By LabMedica International staff writers
Posted on 21 May 2023

Snibe (Shenzhen, China) is showcasing its latest products with high-performance features at Euromedlab Roma 2023, including the newest member of its X-series of new-generation chemiluminescence immunoassay (CLIA) analyzers. More...

MAGLUMI X Tech is the core technology powering the X series of fully automatic CLIA analyzers which provide more efficient, convenient, and reliable immunology diagnostic solutions for laboratories and hospitals. The technology helps the X series analyzers deliver an amazing performance, higher accuracy, and further precision, while also making them affordable and easy to operate. The MAGLUMI X series offers three models to meet all types of demands. The small but smart MAGLUMI X3 is a small-footprint desktop analyzer having a throughput of 200 t/h, 20 reagent positions, and 72 sample positions to target for small- and mid-size laboratories and hospitals.

The most cost-effective analyzer and the newest member of the X-series - MAGLUMI X6 - with a higher throughput of up to 450 T/h offers up to 30 reagent positions and up to 112 sample positions, or up to 412 when integrated with a sample-storage module. The fastest analyzer in the X series - MAGLUMI X8 - is the most powerful CLIA analyzer that offers a super-high throughput of 600 t/h while ensuring the highest level of precision. It offers 42 reagent positions and 300 sample positions. MAGLUMI X8 can be integrated with the Biossays C8 to create the Biolumi CX8 biochemical and immunological integrated analyzer.

Aided by the incredible X Tech, the MAGLUMI X series CLIA analyzers possess even more powerful capabilities such as patented pipetting technology, accurate incubation technology, stable and precise measuring technology, multiple expansion solutions, and user-friendly and high-efficiency loading design. These latest high-end features help the MAGLUMI X series CLIA analyzers to provide better immunology diagnostic capabilities for laboratories and hospitals.

Related Links:
Snibe 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Immunoassay Analyzer
Procise DX
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical Abstract (Ziegler, AG., Rewers, M.J., Achenbach, P. et al. Diabetologia (2026). https://doi.org/10.1007/s00125-026-06841-z)

International Consensus Guidance Outlines General Population Screening for Early-Stage Type 1 Diabetes

Type 1 diabetes (T1D) is an autoimmune disease that can develop in childhood or adulthood and affects an estimated 9.5 million people worldwide. Its complications range from acute diabetic ketoacidosis... Read more

Microbiology

view channel
Image: The current BDBV outbreak in the DRC underscores response challenges for rare, severe infections (Image Credit: 123RF)

Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics

Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read more

Technology

view channel
Image: The 5811 R retains the performance and versatility of its predecessor while adding a new design, a refreshed user interface, and updated sustainable cooling technology. (Photo courtesy of Eppendorf)

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more

Industry

view channel
Image: The combined offering is designed to streamline workflows and support multicolor applications used in leukemia, lymphoma, and measurable residual disease assessment in specialized clinical settings

Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry

Sysmex Europe SE (Hamburg, Germany) and Cytek Biosciences (Fremont, CA, USA) are partnering across more than a dozen European countries to expand access to advanced clinical flow cytometry.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.